Anticoagulants hinder fibrin formation, leading to looser, unstable clots. This weakened structure makes the clot easier to dissolve, reducing the risk of thrombosis.

Anticoagulants disrupt clotting factors, resulting in thinner, less dense fibrin strands. Weaker clots are less likely to block blood flow, thus preventing thrombosis.